HS-20093
Shanghai Hansoh Biomedical
['artemis', 'sclc']
b7-h3 is an attractive target in sclc. in artemis-001, although small number (n=11), orr was 63.6% in sclc. can consider other ways to target b7-h3, such as car t cell therapy. #asco23 
Thoracic Medical Oncologist at Georgetown University | Father/husband/immigrant | #SoMeEditor @ClinicalLung | #LCSM